Steven Hatfill, the virologist who helped push hydroxychloroquine into the national spotlight during the COVID-19 crisis, is back in Washington with a high-level appointment in President Donald Trump’s administration — this time as a senior adviser for pandemic preparedness, The Washington Post reported.
Hatfill now serves as a special adviser in the director’s office at the Administration for Strategic Preparedness and Response, a Department of Health and Human Services division tasked with preparing for biological, chemical, and public health disasters.
In an interview Saturday, Hatfill said he’s focused on helping the agency “get us ready for the next pandemic,” working closely with scientists to analyze the global threat landscape. “Not just for influenza, bird flu, or COVID, but other global diseases that could represent a threat to the U.S.”
Hatfill worked alongside trade adviser Peter Navarro and Trump himself to promote hydroxychloroquine and chloroquine as early treatments for COVID-19 — long before those drugs were scientifically validated or approved for such use. The Trump administration filled the Strategic National Stockpile with millions of doses, many of which were later distributed to hospitals and pharmacies nationwide.
Delusions of Adequacy 